Faculty Summaries
John A Ridge, MD, PhD, FACS
John A Ridge, MD, PhD, FACS
Professor

Recent Publications

  • Andrews G, Lango M, Cohen R, Feigenberg S, Burtness B, Mehra R, Ahmed S, Nicolaou N, Gaughan J, Ridge JA. Non-surgical management of oropharyngeal, laryngeal and hypopharyngeal cancer: the Fox Chase Cancer Center experience. Head Neck, in press, 2010.
  • Rusthoven KE, Feigenberg SJ, Raben D, Kane M, Song JI, Nicolaou N, Mehra R, Burtness B, Ridge J, Swing R, Lango M, Cohen R, Jimeno A, Chen C. Initial results of a phase I dose-escalation trial of concurrent and maintenance erlotinib and reirradiation for recurrent and new primary head and neck cancer. Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1020-5.
  • Turaka A, Li T, Yu JQ, Nicolaou N, Burtness B, Lango MN, Ridge JA, Feigenberg SJ. Intensity Modulated Radiation Therapy (IMRT) for thyroid vancer. 2010;Thyroid Sci. 5:CLS1-5, 2010.
  • Turaka A, Li T, Nicolaou N, Lango MN, Burtness B, Horwitz EM, Ridge JA, Feigenberg SJ. Use of a conventional Low Neck Field (LNF) and Intensity-Modulated Radiotherapy (IMRT): no clinical detriment of IMRT to an anterior LNF During the treatment of head-and neck-cancer. Int J Radiat Oncol Biol Phys. 2010 Apr 10.
  • Turaka A, Li T, Sharma NK, Li L, Nicolaou N, Mehra R, Burtness B, Cohen RB, Lango MN, Horwitz EM, Ridge JA, Feigenberg SJ. Increased recurrences using intensity-modulated radiation therapy in the postoperative setting. Am J Clin Oncol. 2009 Dec 30
  • Martinez E, Tatum KL, Weber DM, Kuzla N, Pendley A, Campbell K, Ridge JA, Langer C, Miyamoto C, Schnoll RA. Issues related to implementing a smoking cessation clinical trial for cancer patients. Cancer Causes Control. 2009 Feb;20(1):97-104.
  • Lango MN, Andrews GA, Ahmad S, Feigenberg S, Tuluc M, Gaughan J, Ridge JA. Postradiotherapy neck dissection for head and neck squamous cell carcinoma: pattern of pathological residual carcinoma and prognosis. Head Neck. 2009 Mar;31(3):328-37.
  • National Comprehensive Cancer Network, Forastiere AA, Ang KK, Brizel D, Brockstein BE, Burtness BA, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Goepfert H, Hicks WL Jr, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pfister DG, Pinto HA, Posner MR, Ridge JA, Samant S, Schuller DE, Shah JP, Spencer S, Trotti A 3rd, Weber RS, Wolf GT, Worden F. Head and neck cancers. J Natl Compr Canc Netw. 2008 Aug;6(7):646-95.
  • Brown KM, Lango M, Ridge, J.A. The role of neck dissection in the combined modality therapy setting. Semin Oncol. 2008;35:229-35.
  • Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A, Gillison ML. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008 Feb 20;100(4):261-9.
  • Willis AI, Ridge JA. Discordant lymphatic drainage patterns revealed by serial lymphoscintigraphy in cutaneous head and neck malignancies. Head Neck. 2007;29:979-985.
  • Feigenberg SJ, Lango M, Nicolaou N, Ridge JA. Intensity-modulated radiotherapy for early larynx cancer: is there a role? Int J Radiat Oncol Biol Phys. 2007 May 1;68(1):2-3.
  • Trotti, A., Pajak, T.F., Gwede, C.K., Paulus, R., Cooper, J., Forastiere, A., Ridge JA, Watkins-Bruner, D., Garden, A.S., Ang, K.K., Curran, W. TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group. Lancet Oncol. 8:613-624, 2007.
  • Kell MR, Ridge JA, Joseph N, Sigurdson ER. PET CT imaging in patients undergoing sentinel node biopsy for melanoma. Eur J Surg Oncol. 2007 Sep;33(7):911-3.
  • Ro EY, Ridge JA, Topham NS. Using stereolithographic models to plan mandibular reconstruction for advanced oral cavity cancer. Laryngoscope. 2007 Apr;117(4):759-61.
  • Poeta ML, Manola J, Goldwasser MA, Forastiere A, Benoit N, Califano JA, Ridge JA, Goodwin J, Kenady D, Saunders J, Westra W, Sidransky D, Koch WM. TP53 mutations and survival in squamous-cell carcinoma of the head and neck. N Engl J Med. 2007 Dec 20;357(25):2552-61.
  • Pfister DG, Ridge JA. Induction chemotherapy for larynx preservation: Patient selection or therapeutic effect? J Clin Oncol. 2006 Feb 1;24(4):540-3.
  • Langer CJ, Duffy K, Horwitz EM, Litwin S, Rosvold E, Schol J, Keenan E, Nicolaou N, Friedman CD, Ridge JA. Phase I trial of concurrent hyperfractionated split course radiotherapy (HFx RT), cisplatin (cDDP), and paclitaxel in patients with recurrent, previously irradiated, or treatment-naive locally advanced upper aerodigestive malignancy. Cancer Invest. 2006 Mar;24(2):164-73.
  • Siegelmann-Danieli N, Ben-Izhack O, Hanlon A, Ridge JA, Stein ME, Khandelwal V, Langer CJ. P53 alteration in oral tongue cancer is not significantly associated with age at diagnosis or tobacco exposure. Tumori. 2005;91:346-50.
  • Schnoll RA, Rothman RL, Wielt DB, Lerman C, Pedri H, Wang H, Babb J, Miller SM, Movsas B, Sherman E, Ridge JA, Unger M, Langer C, Goldberg M, Scott W, Cheng J. A randomized pilot study of cognitive-behavioral therapy versus basic health education for smoking cessation among cancer patients. Ann Behav Med. 2005 Aug;30(1):1-11.
  • Kramer NM, Horwitz EM, Cheng J, Ridge JA, Feigenberg SJ, Cohen RB, Nicolaou N, Sherman EJ, Babb JS, Damsker JA, Langer CJ. Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatln and paclitaxel chemotherapy from two prospective Phase I and II studies. Head Neck. 2005 May;27(5):406-14.
  • Ridge JA, Glisson BS, Horwitz E, Lango M. Head and neck cancer. In: Cancer Management: A Multidisciplinary Approach (Pazdur, R., Coia, L.R., Hoskins, W.J., Wagman, L.D., eds.), pp. 43-90. CMP Healthcare Media, Manhasset, 2005.
  • Henry LR, Ridge JA. Parotidectomy. In: ACS Surgery Principles & Practice (Souba, W.W., Fink, M.P., Jurkovich, L.R., Kaiswer, W.H., Pearce, J.H., Pemberton, N.J., Soper, N.J., eds.), pp. 176-184. Web MD Inc., NY, 2005.
Top